genopole crete sept14 2007

14
Crete meeting on Incubation 1 Crete Meeting on Incubation - 12 September 2007

Upload: ignatiadis

Post on 28-Nov-2014

670 views

Category:

Business


5 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Genopole  Crete Sept14 2007

Crete meeting on Incubation 1

Crete Meeting on Incubation - 12 September 2007

Page 2: Genopole  Crete Sept14 2007

Crete meeting on Incubation 2

Where are we ?

30 Km

Paris Region Bio-cluster

Top 1 in EU for S&T- 7,5 % GDP devoted to R&D -

8 Bioparks Over 150 biotech Cies - 4 000 jobs -

300 public and private research centers 324 pharma Cies - 32 257 jobs -

363 medical equipment Cies - 10 434 jobs -

90% of the French CRO The largest European hospital system

- 41 state-run hospitals (25 000 beds) -

Hot spot for clinical trials

Page 3: Genopole  Crete Sept14 2007

Crete meeting on Incubation 3

Genopole Entreprises

Page 4: Genopole  Crete Sept14 2007

CREATE & EXPAND THE INDUSTRIAL BIOPARK

Increase the number and competitiveness of biotech companies in Evry and the Paris Region by…

- Creating and incubating new start-up companies until market acceptance

- Attracting existing companies

- Supporting companies’ development

GE : OUR MISSION

Page 5: Genopole  Crete Sept14 2007

1998 : 4 companies (110 employees)

2006 : 62 companies (730 employees)

160 Million € raised among VC’s

22 products in RPC & clinical trials

25 companies have total sales of 58 M€

GE : OUR ACHIEVEMENTS

Page 6: Genopole  Crete Sept14 2007

Crete meeting on Incubation 6

53%Biopharma:

17%Material Device

13%Agri BiotechEnvironment

6%Bioinformatics

Informatics

2%Chemistry

9%Others

Sequencing – 1,9%Therapeutic screening – 3,7%Drug delivery – 7,4%Diagnostics – 14,8%Therapeutic research – 25,9%

From Idea to Market acceptance

Cancer Infectious (HIV - HepC)

OphthalmologyMetabolics disorders

AutoimmuneOthers

PII-b – PII-IIIOrphan drug

GE : GENOPOLE COMPANIES

Page 7: Genopole  Crete Sept14 2007

GE : OUR OBJECTIVES 2010

100 companies (2 500 employees)

5 to 10 success stories (IPOs, M&A, Sales)

Products on the market

Attract Big Pharma companies

Page 8: Genopole  Crete Sept14 2007

An expert committee with academic and industrial members (15) in charge of selecting projects

G1J - Genopole pre-seed Capital Fund

Investment / project : 50 000 – 100 000 €, bringing a first entrepreneurial dimension

A Team of 6 multidisciplinary Project Managers + Network of experts

OUR RESOURCES

Page 9: Genopole  Crete Sept14 2007

Crete meeting on Incubation 9

A Comprehensive set of facilities (80 000 m²) ranging from:

- A simple office for the creator (20 to 50 m²)

- A specific biotech ‘greenhouse’ (50 to 400 m²)

- Larger facilities (500 to 2000+ m² )

OUR RESOURCES

Page 10: Genopole  Crete Sept14 2007

Creation of value

Duration

Traditional incubation / 24 months

From First day to First Round

OPERATIONALS FIELDS

Crete meeting on Incubation

Page 11: Genopole  Crete Sept14 2007

Duration

Interaction with Tech Transfer Office

Grants

POC/Market

Think about « scale-up »

Creation of value

OPERATIONALS FIELDS

Page 12: Genopole  Crete Sept14 2007

Duration

Creation of value

- Access to specific skills and expertise :

- Business Development

- Clinical Development

- Regulatory Affairs

- Scale-up

OPERATIONALS FIELDS

Page 13: Genopole  Crete Sept14 2007

Duration

OPERATIONALS FIELDS

Creation of value

Page 14: Genopole  Crete Sept14 2007

Finance

Science(s)

Market Compet.

IP Clinique&Reg Scale up

6

4

2

0

Team

Bus Dev

OPERATIONALS FIELDS